(Q71672854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

1 reference

W G Simpson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

S D Heys

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

P H Whiting

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

O Eremin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

J Broom

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 February 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

143-147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects

20 October 2019

cites work

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

1 reference

12 December 2020

Survival of 727 patients with single carcinomas of the large bowel

1 reference

12 December 2020

Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.

1 reference

12 December 2020

Liver export proteins and trauma

1 reference

12 December 2020

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

12 December 2020

Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells.

1 reference

12 December 2020

IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo

1 reference

12 December 2020

Changing patterns in the treatment of rectal cancer

1 reference

12 December 2020

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

12 December 2020

Clinical and nutritional aspects of changes in acute-phase proteins during inflammation

1 reference

12 December 2020

Acute phase reactant proteins as prognostic indicators in cancer

1 reference

12 December 2020

Cytokines and glucocorticoids in the regulation of the "hepato-skeletal muscle axis" in sepsis

1 reference

12 December 2020

Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice

1 reference

12 December 2020

Chemotherapy of advanced cancer of the colon and rectum

1 reference

12 December 2020

C-reactive protein and the acute phase response

1 reference

12 December 2020

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

1 reference

12 December 2020

Interleukin 2 therapy in cancer: identification of responders

1 reference

12 December 2020

1 reference

12 December 2020

Interleukin 2 therapy: current role in surgical oncological practice

1 reference

12 December 2020

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

1 reference

12 December 2020

Pretreatment serum CRP and response to interleukin 2.

1 reference

12 December 2020

In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses

1 reference

12 December 2020

Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

1 reference

12 December 2020

A rate nephelometer for measuring specific proteins by immunoprecipitin reactions

1 reference

12 December 2020

Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Prognostic significance of serum proteins in invasive bladder cancer. A preliminary report of the E.O.R.T.C. Urological Group

1 reference

12 December 2020

C-reactive protein and the acute phase response

1 reference

12 December 2020

The phenomenon of the acute phase response

1 reference

12 December 2020

Effects of C-reactive protein on human lymphocyte responsiveness

1 reference

12 December 2020

Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer

1 reference

12 December 2020

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

12 December 2020

10.1111/J.1365-2249.1995.TB05524.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7531626%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference